NKG2A/HLA-E Immune Checkpoint Axis in Bladder Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer
Cancer Cell 2022 Sep 12;40(9)1027-1043.e9, B Salomé, JP Sfakianos, D Ranti, J Daza, C Bieber, A Charap, C Hammer, R Banchereau, AM Farkas, DF Ruan, S Izadmehr, D Geanon, G Kelly, RM de Real, B Lee, KG Beaumont, S Shroff, YA Wang, YC Wang, TH Thin, M Garcia-Barros, E Hegewisch-Solloa, EM Mace, L Wang, T O'Donnell, D Chowell, R Fernandez-Rodriguez, M Skobe, N Taylor, S Kim-Schulze, RP Sebra, D Palmer, E Clancy-Thompson, S Hammond, AO Kamphorst, KJ Malmberg, E Marcenaro, P Romero, R Brody, M Viard, Y Yuki, M Martin, M Carrington, R Mehrazin, P Wiklund, I Mellman, S Mariathasan, J Zhu, MD Galsky, N Bhardwaj, A HorowitzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.